Last reviewed · How we verify
Administration of intra-dermal Endorem — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Administration of intra-dermal Endorem (Administration of intra-dermal Endorem) — University of Edinburgh.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Administration of intra-dermal Endorem TARGET | Administration of intra-dermal Endorem | University of Edinburgh | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Administration of intra-dermal Endorem CI watch — RSS
- Administration of intra-dermal Endorem CI watch — Atom
- Administration of intra-dermal Endorem CI watch — JSON
- Administration of intra-dermal Endorem alone — RSS
Cite this brief
Drug Landscape (2026). Administration of intra-dermal Endorem — Competitive Intelligence Brief. https://druglandscape.com/ci/administration-of-intra-dermal-endorem. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab